Страница результатов 13 - Сектор: Здравоохранение Отрасль: Биотехнологии Котировки акций и цены - фондовый рынок
Список всех акций публичных компаний с указанием цен, рыночной капитализации, PE и EPS
Все страны
- {{country.name}}
- Все страны
- Соединенные Штаты (1012)
- Австралия (57)
- Австрия (16)
- Бельгия (7)
- Бразилия (16)
- Канада (83)
- Китай (93)
- Дания (6)
- Финляндия (4)
- Франция (41)
- Германия (739)
- Гонконг (46)
- Индия (19)
- Ирландия (1)
- Израиль (19)
- Италия (4)
- Япония (37)
- Мексика (28)
- Нидерланды (3)
- Новая Зеландия (1)
- Норвегия (15)
- Польша (9)
- Россия (2)
- Южная Корея (20)
- Испания (4)
- Швеция (70)
- Швейцария (11)
- Тайвань (67)
- Таиланд (2)
- Турция (1)
- Великобритания (68)
Все биржи
- {{item.name}}
- Все биржи
- Amsterdam (3)
- ASX (57)
- Brussels (7)
- BSE (9)
- Canadian Sec (30)
- Cboe CA (4)
- Copenhagen (6)
- Dusseldorf (1)
- Frankfurt (648)
- Helsinki (4)
- HKSE (46)
- IOB (25)
- Irish (1)
- Istanbul (1)
- KOSDAQ (10)
- KSE (10)
- MCE (4)
- MCX (2)
- Mexico (28)
- Milan (4)
- Munich (27)
- NSE (10)
- NYSE (11)
- NYSE American (18)
- NYSEArca (1)
- NZSE (1)
- Oslo (15)
- OTC Markets EXMKT (128)
- OTC Markets OTCPK (123)
- OTC Markets OTCQB (35)
- OTC Markets OTCQX (7)
- Other OTC (39)
- Paris (41)
- São Paulo (16)
- Shanghai (47)
- Shenzhen (46)
- Stockholm (70)
- Stuttgart (39)
- Swiss (11)
- Taipei Exchange (59)
- Taiwan (8)
- Tech Market Large (212)
- Tech Market Middle (139)
- Tech Market Small (299)
- Tel Aviv (19)
- Thailand (2)
- Tokyo (37)
- Toronto (19)
- TSXV (30)
- Vienna (16)
- Warsaw (9)
- XETRA (24)
Здравоохранение (2616)
- {{item.name}}
- Все секторы
- Здравоохранение (2616)
Биотехнологии (2616)
- {{item.name}}
- Все отрасли
- Биотехнологии (2616)
- Производители лекарств-Общие (243)
- Производители лекарств-Специализированные и дженерики (1531)
- Планы здравоохранения (56)
- Медицинские учреждения (555)
- Розничные продавцы фармацевтической продукции (156)
- Информационные службы здравоохранения (422)
- Медицинские приборы (922)
- Медицинские инструменты и принадлежности (504)
- Диагностика и исследования (429)
- Медицинская дистрибуция (141)
| Название Название | Цена Цена |
24h% 7d chart 24h% & 7d |
Рын. Кап. Капитализация | Объём Объём | 24ч мин | 24ч макс | Капитализация | Цена/доход | Прибыль на акцию |
|---|
| Название Название | Цена Цена |
24h% 7d chart 24h% & 7d |
Рын. Кап. Капитализация | Объём Объём | 24ч мин | 24ч макс | Капитализация | Цена/доход | Прибыль на акцию | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| GH Research PLC 1KA.F | €11.30 12.35 USD |
-5.04
|
€728.93M 796.82M USD | €13.00 14.21 USD | €11.30 12.35 USD | €11.30 12.35 USD | €728.93M 796.82M USD | 0 | -€0.63 -0.6 USD | |
| Valneva SE AYJ0.F | €7.45 8.14 USD |
+1.36
|
€703.58M 769.11M USD | €350.00 382.6 USD | €7.45 8.14 USD | €7.45 8.14 USD | €703.58M 769.11M USD | 0 | -€0.92 -1.005 USD | |
| Supriya Lifescience Limited SUPRIYA.NS | ₹761.70 9.22 USD |
+2.47
|
₹62.88B 760.8M USD | ₹63.43K 767.35 USD | ₹740.00 8.95 USD | ₹762.30 9.22 USD | ₹62.88B 760.8M USD | 34.38 | ₹22.15 0.27 USD | |
| Valneva SE INRLF | $4.40 — |
-4.35
|
$756.07M — | $175.00 — | $4.40 — | $4.40 — | $756.07M — | 0 | -$0.53 — | |
| Supriya Lifescience Limited SUPRIYA.BO | ₹755.40 9.14 USD |
+1.63
|
₹62.40B 754.96M USD | ₹1.16K 13.97 USD | ₹740.00 8.95 USD | ₹759.80 9.19 USD | ₹62.40B 754.96M USD | 34.11 | ₹22.14 0.27 USD | |
| Replimune Group, Inc. 7R8.F | €7.25 7.93 USD |
+2.84
|
€674.97M 737.83M USD | €200.00 218.63 USD | €7.25 7.93 USD | €7.40 8.09 USD | €674.97M 737.83M USD | 0 | -€3.01 -3.2 USD | |
| Theravance Biopharma, Inc. 0TB.F | €13.30 14.54 USD |
+3.91
|
€674.31M 737.11M USD | €500.00 546.57 USD | €12.90 14.1 USD | €13.30 14.54 USD | €674.31M 737.11M USD | 63.33 | €0.21 0.23 USD | |
| Sunmax Biotechnology Co., Ltd. 4728.TWO | NT$402.00 12.77 USD |
+1.13
|
NT$21.89B 695.69M USD | NT$11.11K 353.09 USD | NT$399.50 12.69 USD | NT$402.00 12.77 USD | NT$21.89B 695.69M USD | 31.30 | NT$12.84 0.41 USD | |
| Takara Bio Inc. TF2.F | €4.74 5.18 USD |
0
|
€624.05M 682.17M USD | €200.00 218.63 USD | €4.74 5.18 USD | €4.84 5.29 USD | €624.05M 682.17M USD | 94.79 | €0.05 0.05 USD | |
| Takara Bio Inc. 4974.T | ¥823 5.56 USD |
-9.06
|
¥99B 668.97M USD | ¥552K 3.73K USD | ¥814 5.49 USD | ¥834 5.63 USD | ¥99B 668.97M USD | 0 | -¥53 -0.3 USD | |
| Viva Biotech Holdings VB0.F | €0.24 0.26 USD |
+5.26
|
€602.68M 658.81M USD | €5.78K 6.32K USD | €0.23 0.25 USD | €0.24 0.26 USD | €602.68M 658.81M USD | 24.00 | €0.01 0.01 USD | |
| Inventiva IVEVF | $4.44 — |
0
|
$647.76M — | $600.00 — | $4.14 — | $4.50 — | $647.76M — | 0 | -$4.35 — | |
| CytomX Therapeutics, Inc. 6C1.F | €3.45 3.77 USD |
+9.88
|
€584.21M 638.62M USD | €1.35K 1.48K USD | €3.45 3.77 USD | €3.56 3.89 USD | €584.21M 638.62M USD | 13.26 | €0.26 0.28 USD | |
| Gossamer Bio, Inc. 4GB.MU | €2.09 2.29 USD |
+2.45
|
€555.23M 606.94M USD | €0.00 0 USD | €0.00 0 USD | €0.00 0 USD | €555.23M 606.94M USD | 0 | -€0.79 -0.8 USD | |
| REGENXBIO Inc. RB0.F | €9.40 10.28 USD |
-3.59
|
€537.45M 587.51M USD | €2.50K 2.73K USD | €9.40 10.28 USD | €9.40 10.28 USD | €537.45M 587.51M USD | 0 | -€3.00 -3.2 USD | |
| Opthea OPT | $3.41 — |
0
|
$583.10M — | $0.00 — | $3.41 — | $3.41 — | $583.10M — | 0 | -$2.25 — | |
| Niagen Bioscience, Inc. OCD1.F | €5.85 6.39 USD |
+1.74
|
€528.71M 577.96M USD | €1.20K 1.31K USD | €5.85 6.39 USD | €5.85 6.39 USD | €528.71M 577.96M USD | 27.85 | €0.21 0.23 USD | |
| Anavex Life Sciences Corp. 12X1.F | €5.80 6.34 USD |
-10.74
|
€528.08M 577.26M USD | €200.00 218.63 USD | €5.61 6.13 USD | €5.93 6.49 USD | €528.08M 577.26M USD | 0 | -€0.49 -0.5 USD | |
| Prestige BioPharma Limited 950210.KS | ₩12,710 9.59 USD |
+4.01
|
₩764B 576.56M USD | ₩124K 93.65 USD | ₩12,250 9.25 USD | ₩12,810 9.67 USD | ₩764B 576.56M USD | 0 | ₩0 0 USD | |
| Viva Biotech Holdings VBIZF | $0.26 — |
0
|
$575.28M — | $100.00 — | $0.30 — | $0.30 — | $575.28M — | 26.35 | $0.01 — | |
| Green Cross Holdings Corporation 005250.KS | ₩16,470 12.43 USD |
+1.98
|
₩752B 567.46M USD | ₩143K 107.69 USD | ₩16,000 12.08 USD | ₩16,620 12.55 USD | ₩752B 567.46M USD | 0 | ₩0 0 USD | |
| Zota Health Care Limited ZOTA.NS | ₹1,544.10 18.68 USD |
+2.33
|
₹46.90B 567.43M USD | ₹7.61K 92.08 USD | ₹1,506.80 18.23 USD | ₹1,548.70 18.74 USD | ₹46.90B 567.43M USD | 0 | -₹21.42 -0.2 USD | |
| KalVista Pharmaceuticals, Inc. 4XC1.F | €10.00 10.93 USD |
+8.7
|
€517.78M 566M USD | €930.00 1.02K USD | €10.00 10.93 USD | €10.00 10.93 USD | €517.78M 566M USD | 0 | -€3.41 -3.7 USD | |
| Green Cross Holdings Corporation 005257.KS | ₩24,750 18.68 USD |
+0.81
|
₩743B 560.97M USD | ₩228 0.17 USD | ₩24,700 18.64 USD | ₩24,900 18.8 USD | ₩743B 560.97M USD | 0 | ₩0 0 USD | |
| Opthea Limited UKJ2.F | €3.00 3.28 USD |
0
|
€512.99M 560.77M USD | €0.00 0 USD | €3.00 3.28 USD | €3.00 3.28 USD | €512.99M 560.77M USD | 0 | -€1.94 -2.1 USD | |
| Akebia Therapeutics, Inc. AX9.F | €1.44 1.57 USD |
+1.06
|
€511.74M 559.41M USD | €41.84K 45.73K USD | €1.44 1.57 USD | €1.44 1.57 USD | €511.74M 559.41M USD | 0 | -€0.16 -0.1 USD | |
| Prothena Corporation plc 0PT.F | €8.95 9.78 USD |
0
|
€511.52M 559.16M USD | €24.00 26.24 USD | €8.95 9.78 USD | €8.95 9.78 USD | €511.52M 559.16M USD | 0 | -€4.50 -4.9 USD | |
| Zevra Therapeutics, Inc. 1GDA.F | €7.80 8.53 USD |
+3.31
|
€510.20M 557.72M USD | €10.00 10.93 USD | €7.80 8.53 USD | €7.80 8.53 USD | €510.20M 557.72M USD | 19.02 | €0.41 0.45 USD | |
| Inventiva S.A. 6IVA.F | €3.14 3.43 USD |
-3.09
|
€508.89M 556.28M USD | €275.00 300.61 USD | €3.00 3.28 USD | €3.14 3.43 USD | €508.89M 556.28M USD | 0 | -€3.76 -4.1 USD | |
| Dishman Carbogen Amcis Limited DCAL.NS | ₹249.05 3.01 USD |
+0.91
|
₹45.70B 552.84M USD | ₹70.53K 853.28 USD | ₹246.00 2.98 USD | ₹251.40 3.04 USD | ₹45.70B 552.84M USD | 28.62 | ₹8.70 0.11 USD | |
| Dishman Carbogen Amcis Limited DCAL.BO | ₹248.95 3.01 USD |
+0.85
|
₹45.64B 552.18M USD | ₹7.95K 96.17 USD | ₹247.00 2.99 USD | ₹251.10 3.04 USD | ₹45.64B 552.18M USD | 28.58 | ₹8.71 0.11 USD | |
| Bicycle Therapeutics plc 50BA.F | €5.65 6.18 USD |
+3.67
|
€501.53M 548.24M USD | €315.00 344.34 USD | €5.45 5.96 USD | €5.65 6.18 USD | €501.53M 548.24M USD | 0 | -€3.14 -3.4 USD | |
| Gossamer Bio, Inc. 4GB.F | €2.09 2.28 USD |
+2.86
|
€498.45M 544.88M USD | €100.00 109.31 USD | €2.06 2.25 USD | €2.09 2.28 USD | €498.45M 544.88M USD | 0 | -€0.60 -0.6 USD | |
| Opthea Limited OPT.AX | A$0.60 0.4 USD |
0
|
A$820.79M 543.24M USD | A$6.21M 4.11M USD | A$0.60 0.39 USD | A$0.62 0.41 USD | A$820.79M 543.24M USD | 0 | -A$0.43 -0.2 USD | |
| Inventiva S.A. 6IV.F | €3.25 3.55 USD |
-5.52
|
€496.09M 542.3M USD | €500.00 546.57 USD | €3.19 3.49 USD | €3.25 3.55 USD | €496.09M 542.3M USD | 0 | -€3.76 -4.1 USD | |
| NovaBridge Biosciences 0VY.F | €3.60 3.94 USD |
-0.55
|
€490.36M 536.03M USD | €4.45K 4.86K USD | €3.60 3.94 USD | €3.60 3.94 USD | €490.36M 536.03M USD | 0 | -€0.44 -0.4 USD | |
| NovaBridge Biosciences IMAB | $4.63 — |
0
|
$533.68M — | $0.00 — | $0.00 — | $0.00 — | $533.68M — | 0 | $0.00 — | |
| Nxera Pharma SOLTF | $5.50 — |
0
|
$497.72M — | $100.00 — | $6.40 — | $6.40 — | $497.72M — | 0 | -$0.23 — | |
| Nxera Pharma Co., Ltd. JSS.F | €4.42 4.83 USD |
0
|
€455.27M 497.67M USD | €400.00 437.25 USD | €4.42 4.83 USD | €4.42 4.83 USD | €455.27M 497.67M USD | 0 | -€0.20 -0.2 USD | |
| Omeros Corporation 3O8.F | €5.90 6.45 USD |
+4.52
|
€450.58M 492.54M USD | €1.08K 1.18K USD | €5.60 6.12 USD | €6.01 6.56 USD | €450.58M 492.54M USD | 0 | -€2.04 -2.2 USD | |
| Altimmune, Inc. ALT1.MX | MX$78.70 4.66 USD |
0
|
MX$8.21B 486.24M USD | MX$1.00 0.06 USD | MX$78.70 4.66 USD | MX$78.70 4.66 USD | MX$8.21B 486.24M USD | 0 | -MX$19.73 -1.1 USD | |
| Opthea Limited UKJ.F | €0.32 0.35 USD |
0
|
€437.75M 478.52M USD | €7.00K 7.65K USD | €0.32 0.35 USD | €0.32 0.35 USD | €437.75M 478.52M USD | 0 | -€0.25 -0.2 USD | |
| DBV Technologies S.A. DBV.F | €2.37 2.59 USD |
-3.07
|
€429.87M 469.91M USD | €510.00 557.5 USD | €2.37 2.59 USD | €2.37 2.59 USD | €429.87M 469.91M USD | 0 | -€0.90 -0.9 USD | |
| Ocugen, Inc. OCGN.MX | MX$24.00 1.42 USD |
0
|
MX$7.72B 457.19M USD | MX$2.00 0.12 USD | MX$24.00 1.42 USD | MX$24.00 1.42 USD | MX$7.72B 457.19M USD | 0 | -MX$4.06 -0.2 USD | |
| Avacta AVCTF | $1.05 — |
0
|
$455.35M — | $26.00K — | $0.96 — | $1.05 — | $455.35M — | 0 | -$0.15 — | |
| Formycon AG FYB.F | €21.35 23.34 USD |
+5.43
|
€407.87M 445.85M USD | €345.00 377.13 USD | €20.35 22.25 USD | €21.75 23.78 USD | €407.87M 445.85M USD | 0 | -€9.67 -10.5 USD | |
| BioInvent International AB (publ) BOVNF | $6.63 — |
+101.61
|
$436.28M — | $908.00 — | $4.70 — | $4.70 — | $436.28M — | 0 | -$0.47 — | |
| Bright Minds Biosciences Inc. DRUG.CN | CA$81.24 60.28 USD |
-2.37
|
CA$575.88M 427.34M USD | CA$0.00 0 USD | CA$0.00 0 USD | CA$0.00 0 USD | CA$575.88M 427.34M USD | 0 | -CA$1.37 -1.01 USD | |
| PureTech Health plc 0VQ0.F | €13.00 14.21 USD |
+3.17
|
€374.29M 409.15M USD | €0.00 0 USD | €13.00 14.21 USD | €13.00 14.21 USD | €374.29M 409.15M USD | 8.84 | €1.47 1.61 USD | |
| PureTech Health PTCHF | $1.68 — |
0
|
$406.03M — | $1.00K — | $1.70 — | $1.70 — | $406.03M — | 9.88 | $0.17 — | |
| PureTech Health PRTC | $16.34 — |
-6.63
|
$394.91M — | $29.92K — | $16.22 — | $17.50 — | $394.91M — | 9.61 | $1.70 — | |
| Oncoinvent ASA BRRGF | $2.50 — |
0
|
$391.60M — | $37.31K — | $0.03 — | $0.03 — | $391.60M — | 0 | -$5.26 — | |
| Avacta Group Plc RTQ1.F | €0.83 0.9 USD |
+5.1
|
€357.77M 391.09M USD | €6.00K 6.56K USD | €0.83 0.9 USD | €0.83 0.9 USD | €357.77M 391.09M USD | 0 | -€0.13 -0.1 USD | |
| Altimmune, Inc. 3G0.F | €3.77 4.12 USD |
+8.99
|
€357.23M 390.5M USD | €800.00 874.51 USD | €3.63 3.96 USD | €3.77 4.12 USD | €357.23M 390.5M USD | 0 | -€0.93 -1.01 USD | |
| Autolus Therapeutics plc 6A3A.F | €1.15 1.26 USD |
0
|
€356.50M 389.7M USD | €1.00K 1.09K USD | €1.15 1.26 USD | €1.15 1.26 USD | €356.50M 389.7M USD | 0 | -€0.75 -0.8 USD | |
| Rocket Pharmaceuticals, Inc. 9IP1.F | €2.53 2.76 USD |
-0.79
|
€348.79M 381.28M USD | €7.90K 8.64K USD | €2.53 2.76 USD | €2.53 2.76 USD | €348.79M 381.28M USD | 0 | -€1.95 -2.1 USD | |
| Clinuvel Pharmaceuticals CLVLF | $7.56 — |
0
|
$379.52M — | $100.00 — | $7.56 — | $7.56 — | $379.52M — | 16.08 | $0.47 — | |
| Antengene Corporation Limited 722.F | €0.51 0.56 USD |
-1.92
|
€345.22M 377.37M USD | €103.00 112.59 USD | €0.51 0.56 USD | €0.51 0.56 USD | €345.22M 377.37M USD | 0 | -€0.04 -0.04 USD | |
| XOMA Royalty Corporation X0M1.F | €28.20 30.83 USD |
-0.7
|
€342.09M 373.95M USD | €13.00 14.21 USD | €28.20 30.83 USD | €28.40 31.05 USD | €342.09M 373.95M USD | 0 | -€1.23 -1.3 USD | |
| Cellectis S.A. ZVAA.F | €2.96 3.24 USD |
+7.25
|
€331.93M 362.85M USD | €1.86K 2.03K USD | €2.96 3.24 USD | €2.96 3.24 USD | €331.93M 362.85M USD | 0 | -€0.28 -0.3 USD | |
| Clinuvel Pharmaceuticals Limited UR9.F | €6.18 6.76 USD |
+1.39
|
€331.80M 362.7M USD | €1.02K 1.11K USD | €6.18 6.76 USD | €6.18 6.76 USD | €331.80M 362.7M USD | 15.44 | €0.40 0.44 USD | |
| Galectin Therapeutics Inc. PHPN.F | €4.56 4.98 USD |
+2.24
|
€331.01M 361.84M USD | €2.00K 2.19K USD | €4.44 4.85 USD | €4.56 4.98 USD | €331.01M 361.84M USD | 0 | -€0.55 -0.6 USD | |
| Clinuvel Pharmaceuticals Limited UR9A.F | €6.00 6.56 USD |
+0.84
|
€329.99M 360.72M USD | €1.68K 1.84K USD | €6.00 6.56 USD | €6.00 6.56 USD | €329.99M 360.72M USD | 15.00 | €0.40 0.44 USD | |
| Flerie AB (publ) 1NP.F | €4.16 4.55 USD |
+1.96
|
€325.60M 355.93M USD | €1.00 1.09 USD | €4.03 4.41 USD | €4.14 4.53 USD | €325.60M 355.93M USD | 0 | -€8.83 -9.6 USD | |
| Gongwin Biopharm Holdings Co., Ltd. 6617.TWO | NT$88.00 2.8 USD |
-2.22
|
NT$10.79B 342.87M USD | NT$64.66K 2.05K USD | NT$87.30 2.77 USD | NT$90.20 2.87 USD | NT$10.79B 342.87M USD | 0 | -NT$0.48 -0.01 USD | |
| Newron Pharmaceuticals S.p.A. NP5.F | €15.08 16.48 USD |
+0.4
|
€311.97M 341.03M USD | €575.00 628.55 USD | €15.08 16.48 USD | €15.08 16.48 USD | €311.97M 341.03M USD | 11.08 | €1.36 1.49 USD | |
| AC Immune SA IMR.F | €2.99 3.27 USD |
-0.33
|
€300.79M 328.81M USD | €2.00K 2.19K USD | €2.82 3.08 USD | €2.99 3.27 USD | €300.79M 328.81M USD | 0 | -€0.77 -0.8 USD | |
| Immutep PRRUF | $0.22 — |
+10.55
|
$325.44M — | $2.50K — | $0.22 — | $0.22 — | $325.44M — | 0 | -$0.03 — | |
| Enanta Pharmaceuticals, Inc. 9EP.F | €10.30 11.26 USD |
+5.64
|
€297.19M 324.86M USD | €54.00 59.03 USD | €9.70 10.6 USD | €10.30 11.26 USD | €297.19M 324.86M USD | 0 | -€3.74 -4.08 USD | |
| Panacea Biotec Limited PANACEABIO.BO | ₹402.65 4.87 USD |
+1.58
|
₹26.62B 322.11M USD | ₹2.19K 26.52 USD | ₹398.50 4.82 USD | ₹407.05 4.92 USD | ₹26.62B 322.11M USD | 216.47 | ₹1.86 0.02 USD | |
| Panacea Biotec Limited PANACEABIO.NS | ₹400.50 4.85 USD |
+0.97
|
₹26.46B 320.11M USD | ₹23.36K 282.58 USD | ₹397.90 4.81 USD | ₹402.45 4.87 USD | ₹26.46B 320.11M USD | 214.17 | ₹1.87 0.02 USD | |
| Healios K.K. 6VX.F | €2.28 2.49 USD |
-8.8
|
€290.78M 317.86M USD | €20.00 21.86 USD | €2.28 2.49 USD | €2.28 2.49 USD | €290.78M 317.86M USD | 0 | -€0.34 -0.3 USD | |
| Cellectis S.A. ZVA.F | €3.01 3.28 USD |
-7.54
|
€286.17M 312.82M USD | €1.25K 1.37K USD | €3.01 3.28 USD | €3.01 3.28 USD | €286.17M 312.82M USD | 0 | -€0.28 -0.3 USD | |
| Larimar Therapeutics, Inc. ZA71.F | €3.02 3.3 USD |
-1.95
|
€282.13M 308.4M USD | €510.00 557.5 USD | €3.02 3.3 USD | €3.02 3.3 USD | €282.13M 308.4M USD | 0 | -€1.70 -1.8 USD | |
| Cellectis S.A. CMVLF | $4.26 — |
-15.48
|
$308.11M — | $100.00 — | $4.26 — | $4.26 — | $308.11M — | 0 | -$0.33 — | |
| Avalo Therapeutics Inc. R C6K0.F | €12.96 14.17 USD |
+0.93
|
€279.94M 306.02M USD | €4.00 4.37 USD | €12.96 14.17 USD | €12.96 14.17 USD | €279.94M 306.02M USD | 0 | -€11.63 -12.7 USD | |
| Frontage FGHQF | $0.15 — |
0
|
$303.75M — | $130.00 — | $0.15 — | $0.15 — | $303.75M — | 0 | $0.00 — | |
| Aldeyra Therapeutics, Inc. 137.F | €4.50 4.92 USD |
+2.55
|
€270.91M 296.14M USD | €520.00 568.43 USD | €4.31 4.71 USD | €4.50 4.92 USD | €270.91M 296.14M USD | 0 | -€0.63 -0.6 USD | |
| Astria Therapeutics, Inc. 2090.MU | €4.74 5.18 USD |
0
|
€267.40M 292.3M USD | €108.00 118.06 USD | €4.74 5.18 USD | €4.74 5.18 USD | €267.40M 292.3M USD | 0 | -€44.71 -48.8 USD | |
| Hansa Biopharma AB (publ) HNSBF | $2.91 — |
0
|
$290.20M — | $150.00 — | $2.93 — | $2.93 — | $290.20M — | 0 | -$0.95 — | |
| scPharmaceuticals Inc. 2SX.F | €4.76 5.2 USD |
0
|
€261.18M 285.51M USD | €0.00 0 USD | €0.00 0 USD | €0.00 0 USD | €261.18M 285.51M USD | 0 | €0.00 0 USD | |
| Oryzon Genomics ORYZF | $3.61 — |
0
|
$284.66M — | $5.00K — | $3.03 — | $3.03 — | $284.66M — | 0 | -$0.07 — | |
| Mereo BioPharma Group plc MAH0.SG | €1.62 1.77 USD |
+7.31
|
€256.94M 280.87M USD | €0.00 0 USD | €1.47 1.61 USD | €1.62 1.77 USD | €256.94M 280.87M USD | 0 | -€0.26 -0.2 USD | |
| Egetis Therapeutics AB (publ) P0F.SG | €0.56 0.61 USD |
+3.7
|
€249.37M 272.6M USD | €500.00 546.57 USD | €0.54 0.59 USD | €0.59 0.65 USD | €249.37M 272.6M USD | 0 | -€0.09 -0.09 USD | |
| Silence Therapeutics plc XRP2.F | €5.25 5.74 USD |
-3.67
|
€247.98M 271.07M USD | €500.00 546.57 USD | €5.25 5.74 USD | €5.25 5.74 USD | €247.98M 271.07M USD | 0 | -€1.17 -1.2 USD | |
| Onward Medical N.V. 63E.F | €4.05 4.43 USD |
+2.53
|
€245.79M 268.68M USD | €140.00 153.04 USD | €3.99 4.36 USD | €4.09 4.47 USD | €245.79M 268.68M USD | 0 | -€0.74 -0.8 USD | |
| Capricor Therapeutics, Inc. 4LN2.F | €4.93 5.38 USD |
-4.55
|
€245.49M 268.35M USD | €200.00 218.63 USD | €4.87 5.32 USD | €4.93 5.38 USD | €245.49M 268.35M USD | 0 | -€1.38 -1.5 USD | |
| ProQR Therapeutics N.V. 0PQ.F | €1.82 1.98 USD |
-2.21
|
€244.82M 267.63M USD | €758.00 828.6 USD | €1.82 1.98 USD | €1.82 1.98 USD | €244.82M 267.63M USD | 0 | -€0.41 -0.4 USD | |
| Eledon Pharmaceuticals, Inc. 2TK.F | €1.90 2.08 USD |
+8.57
|
€242.72M 265.33M USD | €1.00K 1.09K USD | €1.90 2.08 USD | €1.90 2.08 USD | €242.72M 265.33M USD | 3.39 | €0.56 0.61 USD | |
| Oryzon Genomics S.A. ORN.F | €2.84 3.1 USD |
-13.55
|
€241.33M 263.8M USD | €50.00 54.66 USD | €2.84 3.1 USD | €2.84 3.1 USD | €241.33M 263.8M USD | 0 | -€0.06 -0.06 USD | |
| Immutep Limited YP1A.F | €1.46 1.6 USD |
+2.82
|
€240.19M 262.56M USD | €1.70K 1.86K USD | €1.46 1.6 USD | €1.46 1.6 USD | €240.19M 262.56M USD | 0 | -€0.21 -0.2 USD | |
| Voyager Therapeutics, Inc. VYGR.MX | MX$78.50 4.65 USD |
-0.63
|
MX$4.36B 258.44M USD | MX$14.94K 884.63 USD | MX$78.50 4.65 USD | MX$79.20 4.69 USD | MX$4.36B 258.44M USD | 0 | -MX$40.04 -2.3 USD | |
| Mereo BioPharma Group plc MAH0.F | €1.48 1.61 USD |
-4.53
|
€234.67M 256.52M USD | €600.00 655.88 USD | €1.48 1.61 USD | €1.48 1.61 USD | €234.67M 256.52M USD | 0 | -€0.26 -0.2 USD | |
| Editas Medicine, Inc. 8EM.F | €2.18 2.39 USD |
-2.5
|
€233.36M 255.09M USD | €500.00 546.57 USD | €2.14 2.34 USD | €2.18 2.39 USD | €233.36M 255.09M USD | 0 | -€2.04 -2.2 USD | |
| Hansa Biopharma AB (publ) 24H.F | €2.32 2.54 USD |
-1.36
|
€233.03M 254.73M USD | €517.00 565.15 USD | €2.32 2.54 USD | €2.32 2.54 USD | €233.03M 254.73M USD | 0 | -€0.82 -0.8 USD | |
| Immutep Limited YP1B.F | €0.13 0.14 USD |
-0.76
|
€231.83M 253.42M USD | €49.57K 54.19K USD | €0.13 0.14 USD | €0.13 0.14 USD | €231.83M 253.42M USD | 0 | -€0.02 -0.02 USD | |
| Vicore Pharma Holding AB (publ) 6Y4.F | €0.88 0.96 USD |
-5.36
|
€230.45M 251.91M USD | €1.00K 1.09K USD | €0.88 0.96 USD | €0.88 0.96 USD | €230.45M 251.91M USD | 0 | -€0.18 -0.1 USD | |
| Egetis Therapeutics AB (publ) P0F.F | €0.53 0.58 USD |
-5.02
|
€228.40M 249.67M USD | €20.00K 21.86K USD | €0.53 0.58 USD | €0.53 0.58 USD | €228.40M 249.67M USD | 0 | -€0.09 -0.09 USD | |
| Vanda Pharmaceuticals Inc. VM4.F | €3.82 4.18 USD |
+1.06
|
€225.75M 246.77M USD | €4.52K 4.94K USD | €3.78 4.13 USD | €3.82 4.18 USD | €225.75M 246.77M USD | 0 | -€1.25 -1.3 USD | |
| Achieve Life Sciences, Inc. SP4P.F | €3.83 4.18 USD |
-1.92
|
€221.78M 242.43M USD | €2.29K 2.5K USD | €3.83 4.18 USD | €3.83 4.18 USD | €221.78M 242.43M USD | 0 | -€1.17 -1.2 USD | |
|
Нет избранных акций
У вас еще нет любимых акций, пожалуйста, добавьте их в избранное, чтобы увидеть их здесь |
||||||||||